Imperial College London
Alternate

Professor Toby Maher

Faculty of Medicine, National Heart & Lung Institute

Professor of Interstitial Lung Disease
 
 
 
//

Contact

 

+44 (0)20 7594 2151t.maher

 
 
//

Assistant

 

Ms Georgina Moss +44 (0)20 7594 2151

 
//

Location

 

364Sir Alexander Fleming BuildingSouth Kensington Campus

//

Summary

 

Publications

Citation

BibTex format

@article{Maher:2021:10.1183/13993003.02442-2019,
author = {Maher, TM and Costabel, U and Glassberg, MK and Kondoh, Y and Ogura, T and Scholand, MB and Kardatzke, D and Howard, M and Olsson, J and Neighbors, M and Belloni, P and Swigris, JJ},
doi = {10.1183/13993003.02442-2019},
journal = {EUROPEAN RESPIRATORY JOURNAL},
title = {Phase 2 trial to assess lebrikizumab in patients with idiopathic pulmonary fibrosis},
url = {http://dx.doi.org/10.1183/13993003.02442-2019},
volume = {57},
year = {2021}
}
Download

RIS format (EndNote, RefMan)

TY  - JOUR
AU  - Maher,TM
AU  - Costabel,U
AU  - Glassberg,MK
AU  - Kondoh,Y
AU  - Ogura,T
AU  - Scholand,MB
AU  - Kardatzke,D
AU  - Howard,M
AU  - Olsson,J
AU  - Neighbors,M
AU  - Belloni,P
AU  - Swigris,JJ
DO  - 10.1183/13993003.02442-2019
PY  - 2021///
SN  - 0903-1936
TI  - Phase 2 trial to assess lebrikizumab in patients with idiopathic pulmonary fibrosis
T2  - EUROPEAN RESPIRATORY JOURNAL
UR  - http://dx.doi.org/10.1183/13993003.02442-2019
UR  - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000619682500014&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=a2bf6146997ec60c407a63945d4e92bb
VL  - 57
ER  -
Download